Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Not Confirmed
Not Confirmed
03-07 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Industry Trade Show
Not Confirmed
03-07 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
25 May 2023
// Amber Tong ENDPTS
https://endpts.com/fda-approves-antibiotic-for-pneumonia-caused-by-hard-to-treat-bacteria/
17 Apr 2023
// Paul Schloesser ENDPTS
https://endpts.com/adcomm-unanimously-recommends-entasis-bacterial-pneumonia-candidate-for-resistant-infections/
17 Apr 2023
// Paul Schloesser ENDPTS
https://endpts.com/adcomm-unanimously-recommends-entasis-bacterial-pneumonia-candidate-for-resistant-infections/
19 Oct 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/10/19/2537378/0/en/Entasis-Therapeutics-a-Wholly-Owned-Subsidiary-of-Innoviva-Presents-Efficacy-and-Safety-Data-from-Landmark-Phase-3-ATTACK-Trial-at-IDWEEK-2022.html
12 Oct 2022
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2022/10/12/2532897/0/en/Entasis-Therapeutics-a-Wholly-Owned-Subsidiary-of-Innoviva-Announces-Data-on-SUL-DUR-to-be-Presented-at-IDWeek-2022.html
11 Jul 2022
// BUSINESSWIRE
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?